Liquid Biopsy For Personalised Monitoring Of Melanoma Patients
Funder
National Health and Medical Research Council
Funding Amount
$820,888.00
Summary
Despite the success of recent melanoma treatments, therapies are effective long term in only a proportion of patients. Here we will progress preliminary findings in collaboration with biotechnology and pathology companies to develop highly effective companion biomarkers that will aid treatment decisions throughout disease course. Our team will spearhead translation of these markers into the clinic for routine monitoring of melanoma patients.
Deciphering The Role Of Atypical DNA Methylation In Neuronal Genome Regulation And Neurological Disorders
Funder
National Health and Medical Research Council
Funding Amount
$773,484.00
Summary
This research will use a combination of genomic, biochemical and functional genomics approaches to investigate the role of the atypical mCH form of DNA methylation in neuronal genome regulation and function, and provide new insights into the role of the epigenome in healthy brain function and neural pathologies.
Leveraging Genomics Strategies To Generate Adult Neurons From IPSCs And Somatic Cells
Funder
National Health and Medical Research Council
Funding Amount
$1,593,336.00
Summary
Recent advances have made it possible to derive myriad specialized human cells from stem cells or by directly reprogramming cell identity. However, these derived cells are generally arrested at a fetal developmental stage, and do not mature to function like adult cells. We will use new genomic, epigenetic, cell reprogramming, and manipulation methods to discover how to derive mature cells, aiming to generate mature neurons for use in neurobiology research, disease modeling, and drug screening.
EPIGENETIC REPROGRAMMING OF MALIGNANT BREAST CANCER
Funder
National Health and Medical Research Council
Funding Amount
$863,268.00
Summary
Poorly differentiated breast cancers are aggressive tumors, frequently resistant to chemotherapy and associated with high morbidity. Herein we propose the engineering of more selective therapeutic agents able to target the genes involved in cancer initiation and resistance to treatment. We aim to correct and reprogram the cancer cell genome in state that is similar to normal, not tumorigenic cells. This work will generate novel forms of treatment for cancers that are presently not curable.
Flea Control by Immunological Intervention. Fleas are bloodsucking parasites that are the major cause of skin disease in pets. Currently, all available flea products rely upon chemical control and many have active components that have real or perceived health problems. Given that insect growth regulators do not kill adult fleas and pet owners are interested in using alternatives to insecticides, there is a clear need for a complementary form of flea control. We describe the novel use of Prote ....Flea Control by Immunological Intervention. Fleas are bloodsucking parasites that are the major cause of skin disease in pets. Currently, all available flea products rely upon chemical control and many have active components that have real or perceived health problems. Given that insect growth regulators do not kill adult fleas and pet owners are interested in using alternatives to insecticides, there is a clear need for a complementary form of flea control. We describe the novel use of Proteomic technology to identify flea proteins that are "switched on" during feeding and are specifically located in the gut. This project will enable the development of a vaccine that is systemic, kills adult fleas, is long-lasting and residue-free.Read moreRead less
Understanding the molecular basis of virulence in Brachyspira hyodysenteriae to improve vaccine design. Swine dysentery is a colonic infection of pigs caused by Brachyspira hyodysenteriae. The disease is widespread in Australia and causes great economic loss. An effective vaccine is not available. This study aims to identify factors associated with the bacterium's virulence, using comparative genomic and proteomic information. Virulence factors then will be targeted and tested as recombinant vac ....Understanding the molecular basis of virulence in Brachyspira hyodysenteriae to improve vaccine design. Swine dysentery is a colonic infection of pigs caused by Brachyspira hyodysenteriae. The disease is widespread in Australia and causes great economic loss. An effective vaccine is not available. This study aims to identify factors associated with the bacterium's virulence, using comparative genomic and proteomic information. Virulence factors then will be targeted and tested as recombinant vaccine candidates. This project will result in the development of an improved vaccine to control swine dysentery in rural Australia. Control of swine dysentery through vaccination will reduce antibiotic use on infected farms and improve the productivity and competitiveness of the Australian pig industry.Read moreRead less
Genomic sequencing and comparative genomic analysis for animal bacterial vaccine discovery. The aim of this project is to develop vaccines for the control of swine dysentery (pigs) and intestinal spirochaetosis (pigs and chickens). These infections cause important production-limiting diseases for which no effective vaccines are available. We will use whole genomic sequencing of the two causal species of intestinal spirochaetal bacteria, with a bioinformatics-based analysis of the data to identif ....Genomic sequencing and comparative genomic analysis for animal bacterial vaccine discovery. The aim of this project is to develop vaccines for the control of swine dysentery (pigs) and intestinal spirochaetosis (pigs and chickens). These infections cause important production-limiting diseases for which no effective vaccines are available. We will use whole genomic sequencing of the two causal species of intestinal spirochaetal bacteria, with a bioinformatics-based analysis of the data to identify potential cell surface structures that will be tested as the basis of new recombinant vaccines. Outcomes will include the development of new commercial products, increased institutional capacity in veterinary vaccine discovery, and ultimately improved animal health and production in rural Australia.Read moreRead less
Harnessing the genome of the Australian paralysis tick to develop effective control products. This project aims to examine the potent cocktail produced by the salivary gland of Australia's paralysis tick. The paralysis tick continues to cause severe illness and deaths for companion pets with up to 100,000 cases of toxicoses per year. This project aims to develop new safe treatments and/or preventative vaccines.
ARC/NHMRC Research Network for Parasitology. The ARC Network for Parasitology will focus and coordinate Australia's world class fundamental, strategic and applied parasitology research. This targeted approach will raise Australia's standing in the field, assist in the community's understanding of parasitology and biosecurity and maintain and improve Australia's capacity for keeping its stock, crops, wildlife and people disease-free. On an international scale, the Network will work with other cou ....ARC/NHMRC Research Network for Parasitology. The ARC Network for Parasitology will focus and coordinate Australia's world class fundamental, strategic and applied parasitology research. This targeted approach will raise Australia's standing in the field, assist in the community's understanding of parasitology and biosecurity and maintain and improve Australia's capacity for keeping its stock, crops, wildlife and people disease-free. On an international scale, the Network will work with other countries to develop new technologies for the detection and eradication of parasites. This emphasis will not only protect Australia's borders but will assist our near neighbours and lead to the development of technologies with an economic benefit to Australia.
Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0561042
Funder
Australian Research Council
Funding Amount
$852,705.00
Summary
Establishing a high-throughput Protein Production Unit. We seek to establish a world class high-throughput (H-T) protein production unit, the first of its kind in Australia. Throughout the unit robotic technology will be used to build and test protein expression systems as well as drive large scale protein production. The product of the unit will be high quality, pure protein, effective expression systems and world class research. The unit will act as a centre for research into H-T protein ex ....Establishing a high-throughput Protein Production Unit. We seek to establish a world class high-throughput (H-T) protein production unit, the first of its kind in Australia. Throughout the unit robotic technology will be used to build and test protein expression systems as well as drive large scale protein production. The product of the unit will be high quality, pure protein, effective expression systems and world class research. The unit will act as a centre for research into H-T protein expression technology, will underpin the finest biological research, provide the basis for large "structural genomic" type approaches to biological problems and provide a wealth of projects for the Australian synchrotron.Read moreRead less